Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials
García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, Acosta-Olivo CA, Vilchez-Cavazos F, Simental-Mendía LE, et al.. Int Orthop. 2019; 43(3):531–538.
PubMed 30368550 · doi:10.1007/s00264-018-4211-5
Pools the results of several trials. Only as reliable as the trials it includes.
- Who or what was studied
- Randomised placebo-controlled trials of oral collagen in osteoarthritis (number of trials not given in the abstract)
- Design
- Meta-analysis, random-effects model
What it found
Collagen lowered the total WOMAC osteoarthritis score (weighted mean difference −8.00; 95% CI −13.04 to −2.95) and the pain visual analogue scale (−16.57; 95% CI −26.24 to −6.89) compared with placebo. Within WOMAC, the stiffness subscore improved.
What it doesn't show
The WOMAC pain and physical-function subscores did not differ significantly from placebo, so the overall result is mixed. The abstract does not say how many trials were pooled or which collagen products were used.
Funding and conflicts of interest
No funding or conflict-of-interest statement appears in the PubMed record. Check the full text.
Summary written from the study's abstract and checked against PubMed on November 9, 2026. How we check studies. Educational information, not medical advice.
Related studies
- Peptide Supplements and Their Therapeutic Applications in Sports Medicine (Tewari et al., 2026)
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance (Mendias et al., 2026)
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (Vasireddi et al., 2025)
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (McGuire et al., 2025)